Book Value per Share: BeiGene (ONC)

Graphic logo of BeiGene (ONC)

The book value per share for BeiGene Ltd (ONC) helps assess the expansion of Brukinsa and the effectiveness of R&D cost controls. Current capital volatility is driven by high research expenditures amid growing sales. The global rollout of new therapies is creating real momentum for development. The latest value is recorded as 45.51, which clearly illustrates the stepped changes in the company's equity following the publication of quarterly reports.

ONC (BeiGene Corp) Book Value per Share history from 07/04/2022 to 10/27/2026

Summary analytical data breakdowns for beigene.com (ONC)

- price and consensus price forecast:
Stock Price BeiGene Corp|ONC - Consensus Target
- market capitalization data:
Market Capitalization BeiGene Ltd|ONC - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share BeiGene|ONC - Book Capitalization|Market Value to Book Value Ratio beigene.com|ONC - Total Business Assets
- debt and liquidity data:
Total Debt to Capital BeiGene Ltd|ONC - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital BeiGene|ONC - Company Cumulative Debt|Debt to Book Capitalization Ratio BeiGene Ltd
Fundamental company valuation:ONC BeiGene Corp
Flagship merchandise of beigene.com

Book value per share reflects the portion of net equity available to the security holder after all liabilities are settled. The calculation is based on the ratio of equity to the number of shares. By analyzing the key book value metric on GURU.Markets, an investor can see the impact of BeiGene Ltd (ONC) ESG investments in sustainable waste disposal on its assets. This indicator's trend confirms the fundamental stability of the business, while the upward trajectory signals a strengthening of the company's material base.

Competitor analysis

HALO: Book Value per Share|RVMD - Accounting Value per Share|AAPG (Ascentage Pharma Group) - Book Value per Share|cgoncology.com (CGON) - Accounting Value per Share|URGN (UroGen Pharma) - Book Value per Share|Book Value per Share BCAX|Net Assets per Single Share Personalis Corp PSNL|Equity per Share Erasca Oncology (ERAS)|Delcath Systems, Inc. - Book Value per Share|Accounting Value per Share ymabs.com YMAB|AURA (Aura Biosciences) - Book Value per Share|CADL: Net Asset Value per Share|Net Assets per Single Share Accuray Inc. ARAY|Accounting Value of a Share SELLAS Life Sciences Group|ACTU - Accounting Value per Share|Accounting Value of a Share citiusonc.com|Book Value per Share HURA (TuHURA Biosciences, Inc.)|Accounting Value per Share Protara Therapeutics Inc TARA|Accounting Value per Share FATE (Fate Therapeutics Corp)|Aadi Bioscience, Inc. - Book Value per Share|Net Assets per Single Share TScan (TCRX)|CSBR - Accounting Value of a Share|Book Value per Share XBIT|CEL-SCI (CVM) - Net Asset Value per Share|Book Value per Share OS Therapies Inc|Net Assets per Single Share radiopharmtheranostics.com|Artiva Biotherapeutics, Inc. - Book Value per Share|Net Asset Value per Share adlainortye.com (ANL)|Book Value per Share VERU|Net Assets per Share Tempest Therapeutics Inc TPST|Book Value per Share XLO|RENB - Book Value of One Share|Book Value per Share MURA|KAPA (Kairos Pharma) - Net Asset Value per Share|Net Assets per Single Share OnKure Therapeutics, Inc. (OKUR)|Equity per Share CytoMed|Curis, Inc. - Book Value per Share|Net Asset Value per Share apollomicsinc.com APLM|Accounting Value per Share Tharimmune, Inc.|Advanced Biomed Inc. - Accounting Value of a Share|GNPX - Net Assets per Single Share|Calidi Biotherapeutics (CLDI) - Net Assets per Single Share|SBFM - Accounting Value per Share|Xenetic Biosciences, Inc. (XBIO) - Book Price of a Share|Book Value per Share Salarius Pharmaceuticals (SLRX)|Equity per Share PPBT|American Oncology Network - Net Assets per Single Share|Net Asset Value per Share BGNE (BeiGene Ltd.)|CKPT - Net Assets per Single Share|Equity per Share elevationoncology.com ELEV|ICAD: Book Value per Share|IKNA - Accounting Value per Share|NTBL (Notable Labs) - Book Value per Share|Viracta Therapeutics, Inc. (VIRX) - Accounting Value per Share|MOR (MorphoSys Corp) - Book Value per Share|Book Value per Share NAYA|Net Assets per Single Share Ascentage Pharma Group AAPGV